Novartis has terminated a phase 2 trial evaluating an investigational ADAMTS-5 inhibitor for patients with osteoarthritis knee pain. | Novartis has terminated a phase 2 trial evaluating an ...

Osteoarthritis (OA) is one of the most prevalent conditions affecting tens of millions of U.S. adults, traditionally ...

DelveInsight's “Musculoskeletal Pain Market Insight, Epidemiology and Market Forecast – 2034” report delivers an in-depth ...

Market OverviewThe Global Osteoarthritis Pain Drugs Market is valued at USD 10.32 Billion in 2023 and is projected to reach a value of USD 17.96 Billion by 2032 at a CAGR (Compound Annual Growth Rate) ...

Osteoarthritis is a common chronic health condition that is characterised by joint pain and restricted movement. The main ...

Boston Celtics coach Joe Mazzulla has confirmed a report that Jaylen Brown received injections during the week to help his ...

You don’t have to live with knee pain. As one of the largest joints in our body, our knees endure a lot over a lifetime, ...

The Department of Health - Abu Dhabi (DoH), has successfully completed a groundbreaking clinical trial in Abu Dhabi, in ...

I thought lead poisoning was a Victorian-era problem long consigned to the past. But latest figures show that in 2023 more ...

Successful completion of groundbreaking stem cell trial for knee osteoarthritis marks a significant medical milestone.

Behind-the-knee pain could be due to muscle strain or arthritis—or something far more serious. Orthopedic experts say these ...